Evidence map›Paper›PMID 31333480›Full record

ReviewFrontiers in physiology2019

Coexisting Frailty With Heart Failure.

Izabella Uchmanowicz, Jadwiga Nessler, Robbert Gobbens, Andrzej Gackowski, Donata Kurpas, Ewa Straburzynska-Migaj, Marta Kałuzna-Oleksy, Ewa A Jankowska

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pathophysiology and Management of Heart Failure in the Elderly.The International journal of angiology : official publication of the International College of Angiology, Inc · 2022
    Article
  11. Machine Learning Approaches for the Frailty Screening: A Narrative Review.International journal of environmental research and public health · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Izabella UchmanowiczDepartment of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, Wroclaw, Poland.
Jadwiga NesslerDepartment of Coronary Heart Disease, Institute of Cardiology, Jagiellonian University Medical College, The John Paul II Hospital, Krakow, Poland.
Robbert GobbensFaculty of Health, Sports and Social Work, Inholland University of Applied Sciences, Amsterdam, Netherlands.
Andrzej GackowskiDepartment of Coronary Heart Disease, Institute of Cardiology, Jagiellonian University Medical College, The John Paul II Hospital, Krakow, Poland.
Donata KurpasDepartment of Family Medicine, Faculty of Postgraduate Medical Training, Wroclaw Medical University, Wroclaw, Poland.
Ewa Straburzynska-MigajDepartment of Cardiology, Faculty of Medicine, Poznan University of Medical Science, Poznan, Poland.
Marta Kałuzna-OleksyDepartment of Coronary Heart Disease, Institute of Cardiology, Jagiellonian University Medical College, The John Paul II Hospital, Krakow, Poland.
Ewa A JankowskaCardiology Department, Centre for Heart Diseases, 4th Military Clinical Hospital in Wrocław, Wrocław, Poland.
Institute of Cardiology · PLWroclaw Medical University · PLJagiellonian University · PLPoznan University of Medical Sciences · PLUniversity of Antwerp · BEWroclaw Research Centre EIT+ (Poland) · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

People over 65 years of age constitute over 80% of patients with heart failure (HF) and the incidence of HF is 10 per 1,000 in people aged above 65 years. Approximately 25% of older patients with HF exhibit evidence of frailty. Frail patients with cardiovascular disease (CVD) have a worse prognosis than non-frail patients, and frailty is an independent risk factor for incident HF among older people. Planning the treatment of individuals with HF and concomitant frailty, one should consider not only the limitations imposed by frailty syndrome (FS) but also those associated with the underlying heart disease. It needs to be emphasized that all patients with HF and concomitant FS require individualized treatment.

Indexed as

cardiovascular diseaseelderlyfrailty syndromeheart failuremanagementtherapeutic concepts

Identifiers

PMID31333480
PMCPMC6616269
OpenAlexW2955417028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.